Drug Development Thematic Scorecard 

Our thematic screen ranks companies based on leadership in the 10 themes that matter most to their sector. We identify which companies are prepared for a world filled with multiple disruptive threats, helping you to establish your own company vision for the future. In the drug development sector, the most disruptive themes include immuno-oncology, precision and personalized medicine, and biosimilars, alongside regenerative medicine, rare diseases, and genomics. Drug development companies that invest in the right themes will be successful. Those that miss the critical themes are more likely to end up as failures. GlobalData’s thematic research ecosystem has a proven track record of identifying the important themes early, enabling you to make the right investments ahead of the competition to secure that all-important competitive advantage.